John Sharp Net Worth & Insider Trades

John Sharp - Chief Financial Officer, Phasebio Pharmaceuticals Inc

As of November 23, 2020

What is John Sharp's Net Worth?

The current estimated net worth of Phasebio Pharmaceuticals Inc's Chief Financial Officer, John Sharp, is estimated to be about $9.36M . John Sharp owns about 5,000 units of Phasebio Pharmaceuticals Inc common stock. In the last 2 years at Phasebio Pharmaceuticals Inc, John Sharp has sold an estimated value of $0 worth.

What is John Sharp's Past Insider Trading?

John Sharp's largest purchase order was 5,000 units , worth over $19.2K on December 11, 2018. In total, John Sharp has made about 7 transactions over 2 years of their time at Phasebio Pharmaceuticals Inc. John Sharp usually trades in August, with the busiest year in 2019 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

John P Sharp

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is John Sharp's' Mailing Address?

  • Mailing address is 11119 North Torrey Pines Road, Ste 200 La Jolla CA 92037 CA

What are Phasebio Pharmaceuticals Inc's Past Insider Trades?

Phasebio Pharmaceuticals Inc's most recent insider trade came on October 26, 2022 by New Enterprise Associates Lp, Nea Partners Limited Partnership, Nea GP Ltd, Scott Sandell, Patrick Kerins and Forest Baskett who sold 1,784,109 units worth $262.26K . In the last 4 years, insiders at Phasebio Pharmaceuticals Inc have sold an estimated value of $355.73K and bought an estimated value of $15.77M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Jonathan Mow, Chief Executive Officer,  John P Sharp, Chief Financial Officer,  and Clay Thorp, Director .

PhaseBio Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...